Cathy N Lam

Array ( [id] => 5386405 [patent_doc_number] => 20090227650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Novel crystalline forms of Lestaurtinib' [patent_app_type] => utility [patent_app_number] => 12/355284 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 19503 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227650.pdf [firstpage_image] =>[orig_patent_app_number] => 12355284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392274 [patent_doc_number] => 20090209587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'REPAGLINIDE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/352784 [patent_app_country] => US [patent_app_date] => 2009-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7106 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209587.pdf [firstpage_image] =>[orig_patent_app_number] => 12352784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544590 [patent_doc_number] => 20100016258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'PHOSPHONATE DERIVATIVES AS AUTOTAXIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/351550 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9108 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016258.pdf [firstpage_image] =>[orig_patent_app_number] => 12351550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495414 [patent_doc_number] => 20100010009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl porteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/319549 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37066 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010009.pdf [firstpage_image] =>[orig_patent_app_number] => 12319549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343294 [patent_doc_number] => 20090181944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'METHOD FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/348464 [patent_app_country] => US [patent_app_date] => 2009-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17638 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181944.pdf [firstpage_image] =>[orig_patent_app_number] => 12348464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113315 [patent_doc_number] => 20110190278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'BICYCLIC HETEROCYCLIC DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/809489 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122104 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190278.pdf [firstpage_image] =>[orig_patent_app_number] => 12809489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501756 [patent_doc_number] => 20090162444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'RALOXIFENE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/339975 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2467 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162444.pdf [firstpage_image] =>[orig_patent_app_number] => 12339975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352591 [patent_doc_number] => 20100331378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'AMINOTRIAZOLE DERIVATIVES AS ALX AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/809545 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60410 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331378.pdf [firstpage_image] =>[orig_patent_app_number] => 12809545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350766 [patent_doc_number] => 20100249147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'SULFONYL-SUBSTITUTED 6-MEMBERED RING DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/745761 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16006 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249147.pdf [firstpage_image] =>[orig_patent_app_number] => 12745761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629002 [patent_doc_number] => 20100004247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'COMBINATION COMPRISING A MEK INHIBITOR AND AN AURORA KINASE INHIBITOR 188' [patent_app_type] => utility [patent_app_number] => 12/332068 [patent_app_country] => US [patent_app_date] => 2008-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14351 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004247.pdf [firstpage_image] =>[orig_patent_app_number] => 12332068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958446 [patent_doc_number] => 20110182833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Carboxamide Derivatives Having Cooling Properties' [patent_app_type] => utility [patent_app_number] => 12/745019 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3791 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182833.pdf [firstpage_image] =>[orig_patent_app_number] => 12745019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576000 [patent_doc_number] => 20090143362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'CARBAMAZEPINE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/328027 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3218 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143362.pdf [firstpage_image] =>[orig_patent_app_number] => 12328027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576316 [patent_doc_number] => 20100273786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'TETRAHYDRO-IMIDAZ0[1,5-A]PYRAZINE DERIVATIVES, PREPARATION PROCESS AND MEDICINAL USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/743795 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31913 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273786.pdf [firstpage_image] =>[orig_patent_app_number] => 12743795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9827869 [patent_doc_number] => 08937098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-20 [patent_title] => 'Dermatological compositions comprising at least one naphthoic acid compound and at least one film-forming agent and treatment of keratinization disorders therewith' [patent_app_type] => utility [patent_app_number] => 12/276584 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6057 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12276584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536694 [patent_doc_number] => 20100124571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'Use of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles' [patent_app_type] => utility [patent_app_number] => 12/274831 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6454 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20100124571.pdf [firstpage_image] =>[orig_patent_app_number] => 12274831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352438 [patent_doc_number] => 20100331365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'PIPERIDINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/864878 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31167 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331365.pdf [firstpage_image] =>[orig_patent_app_number] => 12864878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575034 [patent_doc_number] => 20090142395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'DEFERASIROX PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/274281 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7228 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142395.pdf [firstpage_image] =>[orig_patent_app_number] => 12274281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055803 [patent_doc_number] => 20110112163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'CBI DERIVATIVES SUBJECT TO REDUCTIVE ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/742616 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9728 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112163.pdf [firstpage_image] =>[orig_patent_app_number] => 12742616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945152 [patent_doc_number] => 20110105772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'CRYSTALLINE FORMS OF TIGECYCLINE HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 12/742706 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5816 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105772.pdf [firstpage_image] =>[orig_patent_app_number] => 12742706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6632399 [patent_doc_number] => 20100311841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'SYNTHETIC SPHINGOLIPID ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/742036 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3984 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311841.pdf [firstpage_image] =>[orig_patent_app_number] => 12742036 [rel_patent_id] =>[rel_patent_doc_number] =>)